Skip to main content

Table 1 Description of cohort of subjects used in the study

From: Changes in the innate immune response to SARS-CoV-2 with advancing age in humans

No of subjects

Sex

Age range (Years)

Disease

Vaccinated

10 (Young)

Female

21–40

none

yes

10 (Young)

Male

21–40

none

yes

12 (Middle-aged)

Female

41–63

none

yes

8(Middle-aged)

Male

41–63

none

yes

2 (Aged)

female

68–90

none

yes

5 (Aged)

female

68–90

HTN + Hyper Lipidemia

yes

2 (Aged)

female

68–90

HTN + DM2

yes

3 (Aged)

female

68–90

HTN

yes

6 (Aged)

Male

68–85

HTN and DM2

yes

2 (Aged)

Male

68–85

none

yes

  1. N = 20/each age group
  2. HTN-hypertension; DM2- Type 2 Diabetes Mellitus. All older subjects received Moderna or Pfizer vaccine or a combination of both. The information of vaccine brand for young and middle-aged subjects was not collected.